NL-OMON28552RecruitingNot Applicable
Breast density in women with familial risk as indicator for the use of mammography or MRI to screen for breast cancer: A RCT.
Erasmus MC, Daniel den Hoed Clinic, Faculty of Medicine, Department of Surgical Oncology0 sites2,000 target enrollmentStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Recruiting
- Sponsor
- Enrollment
- 2,000
Study Overview
Brief Summary
/A
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •1. Cumulative Life Time Risk ≥20%, defined by Claus Adjusted Tables;
- •2. Age at inclusion 30-55 years, or 5 years younger than youngest case of breast cancer in family;
Exclusion Criteria
- •1. Personal history of invasive (breast) cancer, except for basal cell carcinoma;
- •2. Having a (50% risk of a) known BRCA1, BRCA2 or P53 mutation;
Investigators
Similar Trials
Completed
Not Applicable
Effect of Bazedoxifene, Raloxifene, and Placebo on Breast DensityBreast CancerNCT00418236Wyeth is now a wholly owned subsidiary of Pfizer400
Completed
Not Applicable
Histology of Functional Density in Postmenopausal BreastDense BreastsBreast CancerNCT01240278Mayo Clinic25
Completed
Not Applicable
Cell Lines From High-Risk Breast TissueHealthyNCT00032201National Cancer Institute (NCI)43
Completed
Not Applicable
Genetics of Mammographic Appearances and Patterns (The GenMap Study)Benign Breast DiseaseNCT01160510National Cancer Institute (NCI)106
Completed
Not Applicable
FH-Risk 2.0: Updating Breast Cancer Risk EstimatesBreast Cancer RiskNCT05082740University of Manchester333